Cell Biology · Recruiting
Gut Microbiome Signatures in Type 2 Diabetes Remission
Dietary remission programmes work for some patients and not others, and clinicians have no way to predict who will respond.
Principal investigator: Dr. Lindiwe Dube
Programme
40+
Active programmes across clinical, agri and environmental science
60+
Partner institutions, hospitals and grower networks
180
Peer-reviewed publications and field reports to date
Objectives
- Profile the gut microbiome of 800 participants entering remission programmes
- Identify predictive taxa and metabolic pathways
- Prototype a clinic-ready stratification test
Methodology
- 1Prospective cohort
- 2Shotgun metagenomics
- 3Continuous glucose monitoring
- 4Machine-learning stratification
Partners
- Diabetes Association
- Regional Nutrition Institute
Publications
Connected
Laboratories and services behind this study
Genomics Laboratory
Sequencing, genotyping and bioinformatics
ExploreClinical Diagnostics Laboratory
Chemistry, haematology and immunoassay
ExploreMolecular Diagnostic Panel
Multiplex PCR detection of clinically relevant pathogens from a single sample.
ExploreResearch lifecycle
From a question worth asking to a result people can use
01
Scoping
Define the decision, the endpoint and the population or field site with our partners.
02
Protocol & ethics
Pre-registered protocol, ethics or biosafety approval and consent frameworks.
03
Execution
Accredited laboratory and field workflows with monitored data capture.
04
Translation
Peer-reviewed publication, regulatory dossiers and hand-off to service teams.
Partner with us
Collaborate on Gut Microbiome Signatures in Type 2 Diabetes Remission
Bring us a study, a sample set or a field problem. We scope feasibility, ethics and timelines within one working week.
Publications & data access
Request pre-prints, anonymised datasets or replication protocols from any completed programme.